Breaking News Instant updates and real-time market news.

NVAX

Novavax

$2.26

0.095 (4.39%)

13:50
12/19/18
12/19
13:50
12/19/18
13:50

New position in Novavax calls is part of a bullish theme in the biotech

New position in Novavax calls is part of a bullish theme in the biotech. Shares up 8c to $2.24 and 10K Apr 2.5 calls trade 90c when bid-ask was 70 to 90c. 11.4K changed hands against 2.2K open interest and the call buying today comes two days after 6.3K Jan 4 and 1K Jan 3.5 calls opened Monday. Apr 3 calls saw notable buying last week and represent the largest OI block in the name at 32K contracts. Total open interest is lopsided more than 6:1 at 156K calls and 24K puts.

NVAX Novavax
$2.26

0.095 (4.39%)

12/18/18
LTCO
12/18/18
INITIATION
Target $3
LTCO
Buy
Ladenburg sees 'transformational' data from Novavax in Q1, starts at Buy
Ladenburg Thalmann analyst Michael Higgins initiated coverage of Novavax with a Buy rating and $3 price target. The firm previously had a Buy rating on the shares with the same price target under analyst Kevin DeGeeter. Higgins looks for "transformational" data in Q1 of 2019. The company is developing ResVax, which could become the first vaccine against respiratory syncytial virus, a significant health concern for both infants and older adults, the analyst tells investors in a research note. He points out that Novavax is also developing a "potent" non-egg-based flu vaccine called NanoFlu that he believes could become the new standard of care. The company is approaching a "major turning point" with both pivotal RSV vaccine data and Phase 2 NanoFlu data expected in Q1, says Higgins.
12/18/18
LTCO
12/18/18
INITIATION
Target $3
LTCO
Buy
Novavax reinstated with a Buy at Ladenburg
Ladenburg Thalmann analyst Michael Higgins started Novavax with a Buy rating and $3 price target. The firm previously had a Buy rating on the shares with the same price target under analyst Kevin DeGeeter.
12/10/18
OPCO
12/10/18
INITIATION
Target $4
OPCO
Outperform
Novavax initiated with an Outperform at Oppenheimer
Oppenheimer analyst Kevin DeGeeter started Novavax with an Outperform rating and $4 price target. The analyst believes the company's respiratory syncytial virus program will generate $250M-plus in peak sales due to its first-to-market position and potential for upside from off-label use in elderly. He also views the NanoFlu vaccine program as underappreciated, with upside based on potential for better potency than market share leader FluZone.
11/26/18
PIPR
11/26/18
UPGRADE
Target $4
PIPR
Overweight
Novavax upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff upgraded Novavax to Overweight from Neutral and doubled his price target for the shares to $4 from $2. The stock closed Friday up 1c to $1.72. Novavax completed enrollment of 4,636 pregnant women in the Phase III Prepare trial of ResVax with top-line data expected in Q1 of 2019, Tenthoff tells investors in a research note. Positive results could position the company to file with the FDA and European Medicines Agency by Q1 of 2020, adds the analyst. Further, Tenthoff points out that Novavax completed enrollment of 1,375 healthy adults in the Phase II study of quadrivalent NanoFlu with top-line immunogenicity data also expected in Q1 of 2019. He upgrades the shares ahead of the data readouts.

TODAY'S FREE FLY STORIES

PPL

PPL Corp.

$32.74

0.09 (0.28%)

05:57
10/23/19
10/23
05:57
10/23/19
05:57
Downgrade
PPL Corp. rating change  »

PPL Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

KO

Coca-Cola

$53.87

-0.37 (-0.68%)

05:56
10/23/19
10/23
05:56
10/23/19
05:56
Upgrade
Coca-Cola rating change  »

Coca-Cola upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOK

Stoke Therapeutics

$23.02

0.47 (2.08%)

05:55
10/23/19
10/23
05:55
10/23/19
05:55
Conference/Events
Stoke Therapeutics management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WU

Western Union

$24.25

-0.1 (-0.41%)

05:29
10/23/19
10/23
05:29
10/23/19
05:29
Hot Stocks
Western Union announces new partners in Asia »

Western Union further…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 31

    Oct

LNG

Cheniere Energy

$63.88

0.15 (0.24%)

05:28
10/23/19
10/23
05:28
10/23/19
05:28
Upgrade
Cheniere Energy rating change  »

Cheniere Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

THLEF

Thales

$0.00

(0.00%)

05:27
10/23/19
10/23
05:27
10/23/19
05:27
Downgrade
Thales rating change  »

Thales downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIM

Kimco Realty

$21.40

0.17 (0.80%)

05:26
10/23/19
10/23
05:26
10/23/19
05:26
Downgrade
Kimco Realty rating change  »

Kimco Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

ROIC

Retail Opportunity

$18.94

0.025 (0.13%)

05:26
10/23/19
10/23
05:26
10/23/19
05:26
Upgrade
Retail Opportunity rating change  »

Retail Opportunity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 11

    Nov

ING

ING Group

$11.52

-0.04 (-0.35%)

05:25
10/23/19
10/23
05:25
10/23/19
05:25
Upgrade
ING Group rating change  »

ING Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SWSDF

Swiss Life

$0.00

(0.00%)

05:24
10/23/19
10/23
05:24
10/23/19
05:24
Downgrade
Swiss Life rating change  »

Swiss Life downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRAD

LRAD Corporation

$3.35

-0.1 (-2.90%)

, GNSS

Genasys

$3.35

-0.1 (-2.90%)

05:22
10/23/19
10/23
05:22
10/23/19
05:22
Hot Stocks
LRAD Corporation announces rebranding to 'Genasys', new symbol 'GNSS' »

LRAD Corporation…

LRAD

LRAD Corporation

$3.35

-0.1 (-2.90%)

GNSS

Genasys

$3.35

-0.1 (-2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$46.15

-1.1 (-2.33%)

05:21
10/23/19
10/23
05:21
10/23/19
05:21
Initiation
Crowdstrike initiated  »

Crowdstrike initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

05:20
10/23/19
10/23
05:20
10/23/19
05:20
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UXIN

Uxin

$2.72

0.07 (2.64%)

05:19
10/23/19
10/23
05:19
10/23/19
05:19
Downgrade
Uxin rating change  »

Uxin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.00

-0.58 (-3.98%)

05:18
10/23/19
10/23
05:18
10/23/19
05:18
Upgrade
Snap rating change  »

Snap upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

IRBT

iRobot

$53.88

-1.82 (-3.27%)

05:17
10/23/19
10/23
05:17
10/23/19
05:17
Recommendations
iRobot analyst commentary  »

iRobot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 09

    Dec

HINOY

Hino Motors

$0.00

(0.00%)

05:13
10/23/19
10/23
05:13
10/23/19
05:13
Upgrade
Hino Motors rating change  »

Hino Motors upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

05:10
10/23/19
10/23
05:10
10/23/19
05:10
Recommendations
ServiceNow analyst commentary  »

ServiceNow shares may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

LAMR

Lamar Advertising

$83.25

0.44 (0.53%)

05:05
10/23/19
10/23
05:05
10/23/19
05:05
Downgrade
Lamar Advertising rating change  »

Lamar Advertising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 12

    Nov

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

05:04
10/23/19
10/23
05:04
10/23/19
05:04
Downgrade
ServiceNow downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Gregg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

CISN

Cision

$10.08

1.63 (19.29%)

05:00
10/23/19
10/23
05:00
10/23/19
05:00
Downgrade
Cision rating change  »

Cision downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CQP

Cheniere Energy Partners

$44.39

-0.44 (-0.98%)

04:58
10/23/19
10/23
04:58
10/23/19
04:58
Downgrade
Cheniere Energy Partners rating change  »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

CEQP

Crestwood Equity

$34.00

0.01 (0.03%)

04:57
10/23/19
10/23
04:57
10/23/19
04:57
Upgrade
Crestwood Equity rating change  »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

04:55
10/23/19
10/23
04:55
10/23/19
04:55
Conference/Events
FBN Securities finance analyst to hold a dinner meeting »

Head of Trading Naso…

AB

AllianceBernstein

$27.90

-0.57 (-2.00%)

, AVLR

Avalara

$64.56

-2.27 (-3.40%)

04:55
10/23/19
10/23
04:55
10/23/19
04:55
Conference/Events
Associated for Financial Professionals to hold a conference »

AFP 2019 will be held in…

AB

AllianceBernstein

$27.90

-0.57 (-2.00%)

AVLR

Avalara

$64.56

-2.27 (-3.40%)

AXP

American Express

$118.64

-0.46 (-0.39%)

BCS

Barclays

$8.43

-0.09 (-1.06%)

BBT

BB&T

$53.46

0.01 (0.02%)

BBD

Banco Bradesco

$8.53

0.38 (4.67%)

BK

BNY Mellon

$46.15

0.48 (1.05%)

BL

BlackLine

$46.13

-1.45 (-3.05%)

BLK

BlackRock

$450.30

-3.49 (-0.77%)

BMO

Bank of Montreal

$74.56

0.1 (0.13%)

C

Citi

$72.08

0.24 (0.33%)

COF

Capital One

$92.16

0.8 (0.88%)

DB

Deutsche Bank

$7.91

-0.175 (-2.16%)

FII

Federated Investors

$31.65

-0.39 (-1.22%)

FITB

Fifth Third

$28.30

0.26 (0.93%)

GS

Goldman Sachs

$209.60

0.3 (0.14%)

HSBC

HSBC

$39.21

0.07 (0.18%)

INTL

INTL FCStone

$39.73

-0.63 (-1.56%)

JPM

JPMorgan

$124.87

1.31 (1.06%)

MS

Morgan Stanley

$45.38

0.38 (0.84%)

MSFT

Microsoft

$136.39

-2.05 (-1.48%)

MTB

M&T Bank

$156.36

2.29 (1.49%)

MUFG

Mitsubishi UFJ

$5.14

-0.005 (-0.10%)

USB

U.S. Bancorp

$56.66

0.47 (0.84%)

V

Visa

$170.89

-5.63 (-3.19%)

WFC

Wells Fargo

$50.63

0.18 (0.36%)

WK

Workiva

$39.09

-1.42 (-3.51%)

SAP

SAP

$131.78

-0.91 (-0.69%)

STT

State Street

$66.03

0.61 (0.93%)

STI

SunTrust

$68.83

0.05 (0.07%)

TD

Toronto-Dominion

$57.01

0.21 (0.37%)

PRU

Prudential

$91.22

0.37 (0.41%)

UBS

UBS

$11.49

-0.04 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 04

    Nov

  • 04

    Nov

  • 05

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 10

    Nov

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

  • 06

    Dec

  • 09

    Dec

  • 10

    Dec

  • 14

    Jan

  • 14

    Jan

  • 14

    Jan

  • 15

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.